{"id":"https://openalex.org/W438392113","doi":"https://doi.org/10.5980/jpnjurol.99.134_1","title":"PD2-4 Survival Advantage of Temsirolimus Validates a Role for Mammalian Target of Rapamycin (mTOR) in the Biology of Advanced Renal Cell Carcinoma","display_name":"PD2-4 Survival Advantage of Temsirolimus Validates a Role for Mammalian Target of Rapamycin (mTOR) in the Biology of Advanced Renal Cell Carcinoma","publication_year":2008,"publication_date":"2008-01-01","ids":{"openalex":"https://openalex.org/W438392113","doi":"https://doi.org/10.5980/jpnjurol.99.134_1","mag":"438392113"},"language":"en","primary_location":{"id":"doi:10.5980/jpnjurol.99.134_1","doi":"https://doi.org/10.5980/jpnjurol.99.134_1","is_oa":true,"landing_page_url":"https://doi.org/10.5980/jpnjurol.99.134_1","pdf_url":"https://www.jstage.jst.go.jp/article/jpnjurol/99/2/99_KJ00004904108/_pdf","source":{"id":"https://openalex.org/S2752698192","display_name":"The Japanese Journal of Urology","issn_l":"0021-5287","issn":["0021-5287","1884-7110"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","medline","poland-20","russia-white-list-4"],"host_organization":"https://openalex.org/P4310313616","host_organization_name":"Japanese Dermatological Association","host_organization_lineage":["https://openalex.org/P4310313616"],"host_organization_lineage_names":["Japanese Dermatological Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Japanese Journal of Urology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://www.jstage.jst.go.jp/article/jpnjurol/99/2/99_KJ00004904108/_pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5050649350","display_name":"Robert A. Figlin","orcid":"https://orcid.org/0000-0002-6323-6075","observed_orcids":["https://orcid.org/0000-0002-6323-6075"]},"institutions":[{"id":"https://openalex.org/I1301076528","display_name":"City Of Hope National Medical Center","ror":"https://ror.org/00w6g5w60","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1301076528"]},{"id":"https://openalex.org/I4210110459","display_name":"City of Hope","ror":"https://ror.org/01z1vct10","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1301076528","https://openalex.org/I4210110459"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Robert A. Figlin","raw_affiliation_strings":["City of Hope Comprehensive Care Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"City of Hope Comprehensive Care Center","institution_ids":["https://openalex.org/I1301076528","https://openalex.org/I4210110459"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5050649350"],"corresponding_institution_ids":["https://openalex.org/I1301076528","https://openalex.org/I4210110459"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.07624129,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"99","issue":"2","first_page":"134","last_page":"134"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10449","display_name":"Renal cell carcinoma treatment","score":0.9452999830245972,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10449","display_name":"Renal cell carcinoma treatment","score":0.9452999830245972,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.04859999939799309,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10458","display_name":"Bladder and Urothelial Cancer Treatments","score":0.00139999995008111,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/temsirolimus","display_name":"temsirolimus","score":1.0},{"id":"https://openalex.org/keywords/mtor-inhibition","display_name":"mTOR inhibition","score":0.7760000228881836},{"id":"https://openalex.org/keywords/advanced-renal-cell-carcinoma","display_name":"advanced renal cell carcinoma","score":0.9589999914169312},{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.781000018119812},{"id":"https://openalex.org/keywords/survival-benefit","display_name":"survival benefit","score":0.6000000238418579},{"id":"https://openalex.org/keywords/mtor-signaling","display_name":"mTOR signaling","score":0.5479999780654907}],"concepts":[{"id":"https://openalex.org/C2776820818","wikidata":"https://www.wikidata.org/wiki/Q7699074","display_name":"Temsirolimus","level":5,"score":0.9847732782363892},{"id":"https://openalex.org/C183713625","wikidata":"https://www.wikidata.org/wiki/Q5282002","display_name":"Discovery and development of mTOR inhibitors","level":4,"score":0.7978916764259338},{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.6785141825675964},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6356269121170044},{"id":"https://openalex.org/C2777472916","wikidata":"https://www.wikidata.org/wiki/Q1164529","display_name":"Renal cell carcinoma","level":2,"score":0.6218907833099365},{"id":"https://openalex.org/C2777921159","wikidata":"https://www.wikidata.org/wiki/Q32089","display_name":"Sirolimus","level":2,"score":0.5488572120666504},{"id":"https://openalex.org/C43060935","wikidata":"https://www.wikidata.org/wiki/Q18043110","display_name":"RPTOR","level":4,"score":0.41649091243743896},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3629533350467682},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3168826699256897},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.29446732997894287},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.27393198013305664},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.2304244041442871},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.08669781684875488}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.5980/jpnjurol.99.134_1","doi":"https://doi.org/10.5980/jpnjurol.99.134_1","is_oa":true,"landing_page_url":"https://doi.org/10.5980/jpnjurol.99.134_1","pdf_url":"https://www.jstage.jst.go.jp/article/jpnjurol/99/2/99_KJ00004904108/_pdf","source":{"id":"https://openalex.org/S2752698192","display_name":"The Japanese Journal of Urology","issn_l":"0021-5287","issn":["0021-5287","1884-7110"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","medline","poland-20","russia-white-list-4"],"host_organization":"https://openalex.org/P4310313616","host_organization_name":"Japanese Dermatological Association","host_organization_lineage":["https://openalex.org/P4310313616"],"host_organization_lineage_names":["Japanese Dermatological Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Japanese Journal of Urology","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.5980/jpnjurol.99.134_1","doi":"https://doi.org/10.5980/jpnjurol.99.134_1","is_oa":true,"landing_page_url":"https://doi.org/10.5980/jpnjurol.99.134_1","pdf_url":"https://www.jstage.jst.go.jp/article/jpnjurol/99/2/99_KJ00004904108/_pdf","source":{"id":"https://openalex.org/S2752698192","display_name":"The Japanese Journal of Urology","issn_l":"0021-5287","issn":["0021-5287","1884-7110"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","medline","poland-20","russia-white-list-4"],"host_organization":"https://openalex.org/P4310313616","host_organization_name":"Japanese Dermatological Association","host_organization_lineage":["https://openalex.org/P4310313616"],"host_organization_lineage_names":["Japanese Dermatological Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Japanese Journal of Urology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9537000060081482,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"score":0.5400000214576721,"display_name":"Zero hunger","id":"https://metadata.un.org/sdg/2"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W438392113.pdf","grobid_xml":"https://content.openalex.org/works/W438392113.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2605547225","https://openalex.org/W2054485350","https://openalex.org/W2026634733","https://openalex.org/W2080322619","https://openalex.org/W2406022066","https://openalex.org/W2386631213","https://openalex.org/W2035577276","https://openalex.org/W2029229070","https://openalex.org/W169489141","https://openalex.org/W2143829338"],"abstract_inverted_index":{"Temsiroiimus,":[0],"a":[1,7],"specific":[2],"inhibiter":[3],"of":[4,14],"mTOR,":[5],"is":[6],"novel":[8],"targeted":[9],"therapy":[10],"for":[11],"the":[12],"treatment":[13],"advanced":[15],"renal":[16],"cell":[17],"carcinoma":[18],"(RCC).In":[19],"preclinical":[20],"models,":[21],"mTOR":[22]},"counts_by_year":[],"updated_date":"2026-09-21T07:43:02.447757","created_date":"2016-06-24T00:00:00"}